# SCYNEXIS, Inc. (SCYX): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for SCYNEXIS, Inc. (SCYX) is 25/100, ranked against 24,000+ stocks in 35 markets (Quality 45, Value 40, Momentum 24, each scored against its sector).

- StockRank: 25/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 45, Value 40, Momentum 24: each a 0-100 percentile within Healthcare.
- Position: #19,934 overall, #1,762 in Healthcare.
- Listing: United States, NCM; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 3.81 USD on 26 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/SCYX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker